Cargando…
iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine
Liver transplantation is the most common treatment for patients suffering from liver failure that is caused by congenital diseases, infectious agents, and environmental factors. Despite a high rate of patient survival following transplantation, organ availability remains the key limiting factor. As...
Autores principales: | Olgasi, Cristina, Cucci, Alessia, Follenzi, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503935/ https://www.ncbi.nlm.nih.gov/pubmed/32867371 http://dx.doi.org/10.3390/ijms21176215 |
Ejemplares similares
-
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021) -
Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A
por: Olgasi, Cristina, et al.
Publicado: (2018) -
iPSC technology-based regenerative medicine for kidney diseases
por: Osafune, Kenji
Publicado: (2021) -
iPSC technology‐based regenerative therapy for diabetes
por: Kondo, Yasushi, et al.
Publicado: (2017) -
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023)